958P - Impact of body mass index (BMI) on outcome in 785 patients (pts) receiving systemic chemotherapy (CT) and bevacizumab (BEV) for primary advanced ovarian cancer (OC) (on behalf of the North-Eastern German Society of Gynaecological Oncology, NOGGO)
| Autor: | Sehouli, J., Mustea, A., Oskay-Oezcelik, G., Grabowski, J., Keller, M., Richter, R., Harde, J., Klawitter, S., Wegenaer, A., Tomé, O., Wimberger, P. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v341-v342 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|